Clinical trial
A Prospective Pilot Study Evaluating Wound Closure With the Application of AC5® Advanced Wound System in the Treatment of Diabetic Foot Ulcers
NCT06028386 is registered in ClinicalTrials.gov with Arch Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Pilot Study Evaluating Wound Closure With the Application of AC5® Advanced Wound System in the Treatment of Diabetic Foot Ulcers
- Lead sponsor
- Arch Therapeutics
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 15, 2023
- Completion date
- August 30, 2024
- Enrollment
- 60 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic foot ulcer, non-healing wound